UPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K/Akt signaling pathway in patients with rheumatoid arthritis

Yan Liu, Yun Feng Pan, You Qiu Xue, Lin Kai Fang, Xing Hua Guo, Xin Guo, Meng Liu, Bi Yao Mo, Meng Ru Yang, Fang Liu, Yun Ting Wu, Nancy Olsen, Song Guo Zheng

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Urokinase-type plasminogen activator receptor (uPAR), is a multifunctional receptor on cell surface, widely present in endothelial cells, fibroblasts, and a variety of malignant cells. Current studies have suggested that uPAR overexpressed on synovial tissues or in synovial fluid or plasma in patients with rheumatoid arthritis (RA). However, there are limited researches regarding the role of uPAR on fibroblast-like synoviocytes of rheumatoid arthritis (RA-FLSs) and its underlying mechanisms. Here, our studies show that the expression of uPAR protein was significantly higher in fibroblast-like synoviocytes (FLSs) from RA than those from osteoarthritis or traumatic injury patients. uPAR gene silencing significantly inhibited RA-FLSs cell proliferation, restrained cell transformation from the G0/G1 phase to S phase, aggravated cell apoptosis, interfered with RA-FLSs cell migration and invasion, and reduced activation of the PI3K/Akt signaling pathway, which may be associated with β1-integrin. Cell supernatants from uPAR gene-silenced RA-FLSs markedly inhibited the migration and tubule formation ability of the HUVECs (a human endothelial cell line). Therefore, we demonstrate that uPAR changes the biological characteristics of RA-FLSs, and affects neoangiogenesis of synovial tissues in patients with RA. All of these may be associated with the β1-integrin/PI3K/Akt signaling pathway. These results imply that targeting uPAR and its downstream signal pathway may provide therapeutic effects in RA.

Original languageEnglish (US)
Pages (from-to)171-181
Number of pages11
JournalCellular and Molecular Immunology
Volume15
Issue number2
DOIs
StatePublished - Feb 1 2018

Fingerprint

Urokinase Plasminogen Activator Receptors
Phosphatidylinositol 3-Kinases
Rheumatoid Arthritis
Fibroblasts
Neoplasms
Integrins
Endothelial Cells
Synoviocytes
Cell Cycle Resting Phase
Aptitude
Synovial Fluid
G1 Phase
Cell Surface Receptors
Gene Silencing
Therapeutic Uses
S Phase
Osteoarthritis
Cell Movement
Signal Transduction
Cell Proliferation

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Cite this

Liu, Yan ; Pan, Yun Feng ; Xue, You Qiu ; Fang, Lin Kai ; Guo, Xing Hua ; Guo, Xin ; Liu, Meng ; Mo, Bi Yao ; Yang, Meng Ru ; Liu, Fang ; Wu, Yun Ting ; Olsen, Nancy ; Zheng, Song Guo. / UPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K/Akt signaling pathway in patients with rheumatoid arthritis. In: Cellular and Molecular Immunology. 2018 ; Vol. 15, No. 2. pp. 171-181.
@article{5be4672ec79644f6bd29aa2bf85fe70f,
title = "UPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K/Akt signaling pathway in patients with rheumatoid arthritis",
abstract = "Urokinase-type plasminogen activator receptor (uPAR), is a multifunctional receptor on cell surface, widely present in endothelial cells, fibroblasts, and a variety of malignant cells. Current studies have suggested that uPAR overexpressed on synovial tissues or in synovial fluid or plasma in patients with rheumatoid arthritis (RA). However, there are limited researches regarding the role of uPAR on fibroblast-like synoviocytes of rheumatoid arthritis (RA-FLSs) and its underlying mechanisms. Here, our studies show that the expression of uPAR protein was significantly higher in fibroblast-like synoviocytes (FLSs) from RA than those from osteoarthritis or traumatic injury patients. uPAR gene silencing significantly inhibited RA-FLSs cell proliferation, restrained cell transformation from the G0/G1 phase to S phase, aggravated cell apoptosis, interfered with RA-FLSs cell migration and invasion, and reduced activation of the PI3K/Akt signaling pathway, which may be associated with β1-integrin. Cell supernatants from uPAR gene-silenced RA-FLSs markedly inhibited the migration and tubule formation ability of the HUVECs (a human endothelial cell line). Therefore, we demonstrate that uPAR changes the biological characteristics of RA-FLSs, and affects neoangiogenesis of synovial tissues in patients with RA. All of these may be associated with the β1-integrin/PI3K/Akt signaling pathway. These results imply that targeting uPAR and its downstream signal pathway may provide therapeutic effects in RA.",
author = "Yan Liu and Pan, {Yun Feng} and Xue, {You Qiu} and Fang, {Lin Kai} and Guo, {Xing Hua} and Xin Guo and Meng Liu and Mo, {Bi Yao} and Yang, {Meng Ru} and Fang Liu and Wu, {Yun Ting} and Nancy Olsen and Zheng, {Song Guo}",
year = "2018",
month = "2",
day = "1",
doi = "10.1038/cmi.2016.60",
language = "English (US)",
volume = "15",
pages = "171--181",
journal = "Cellular and Molecular Immunology",
issn = "1672-7681",
publisher = "Nature Publishing Group",
number = "2",

}

UPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K/Akt signaling pathway in patients with rheumatoid arthritis. / Liu, Yan; Pan, Yun Feng; Xue, You Qiu; Fang, Lin Kai; Guo, Xing Hua; Guo, Xin; Liu, Meng; Mo, Bi Yao; Yang, Meng Ru; Liu, Fang; Wu, Yun Ting; Olsen, Nancy; Zheng, Song Guo.

In: Cellular and Molecular Immunology, Vol. 15, No. 2, 01.02.2018, p. 171-181.

Research output: Contribution to journalArticle

TY - JOUR

T1 - UPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K/Akt signaling pathway in patients with rheumatoid arthritis

AU - Liu, Yan

AU - Pan, Yun Feng

AU - Xue, You Qiu

AU - Fang, Lin Kai

AU - Guo, Xing Hua

AU - Guo, Xin

AU - Liu, Meng

AU - Mo, Bi Yao

AU - Yang, Meng Ru

AU - Liu, Fang

AU - Wu, Yun Ting

AU - Olsen, Nancy

AU - Zheng, Song Guo

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Urokinase-type plasminogen activator receptor (uPAR), is a multifunctional receptor on cell surface, widely present in endothelial cells, fibroblasts, and a variety of malignant cells. Current studies have suggested that uPAR overexpressed on synovial tissues or in synovial fluid or plasma in patients with rheumatoid arthritis (RA). However, there are limited researches regarding the role of uPAR on fibroblast-like synoviocytes of rheumatoid arthritis (RA-FLSs) and its underlying mechanisms. Here, our studies show that the expression of uPAR protein was significantly higher in fibroblast-like synoviocytes (FLSs) from RA than those from osteoarthritis or traumatic injury patients. uPAR gene silencing significantly inhibited RA-FLSs cell proliferation, restrained cell transformation from the G0/G1 phase to S phase, aggravated cell apoptosis, interfered with RA-FLSs cell migration and invasion, and reduced activation of the PI3K/Akt signaling pathway, which may be associated with β1-integrin. Cell supernatants from uPAR gene-silenced RA-FLSs markedly inhibited the migration and tubule formation ability of the HUVECs (a human endothelial cell line). Therefore, we demonstrate that uPAR changes the biological characteristics of RA-FLSs, and affects neoangiogenesis of synovial tissues in patients with RA. All of these may be associated with the β1-integrin/PI3K/Akt signaling pathway. These results imply that targeting uPAR and its downstream signal pathway may provide therapeutic effects in RA.

AB - Urokinase-type plasminogen activator receptor (uPAR), is a multifunctional receptor on cell surface, widely present in endothelial cells, fibroblasts, and a variety of malignant cells. Current studies have suggested that uPAR overexpressed on synovial tissues or in synovial fluid or plasma in patients with rheumatoid arthritis (RA). However, there are limited researches regarding the role of uPAR on fibroblast-like synoviocytes of rheumatoid arthritis (RA-FLSs) and its underlying mechanisms. Here, our studies show that the expression of uPAR protein was significantly higher in fibroblast-like synoviocytes (FLSs) from RA than those from osteoarthritis or traumatic injury patients. uPAR gene silencing significantly inhibited RA-FLSs cell proliferation, restrained cell transformation from the G0/G1 phase to S phase, aggravated cell apoptosis, interfered with RA-FLSs cell migration and invasion, and reduced activation of the PI3K/Akt signaling pathway, which may be associated with β1-integrin. Cell supernatants from uPAR gene-silenced RA-FLSs markedly inhibited the migration and tubule formation ability of the HUVECs (a human endothelial cell line). Therefore, we demonstrate that uPAR changes the biological characteristics of RA-FLSs, and affects neoangiogenesis of synovial tissues in patients with RA. All of these may be associated with the β1-integrin/PI3K/Akt signaling pathway. These results imply that targeting uPAR and its downstream signal pathway may provide therapeutic effects in RA.

UR - http://www.scopus.com/inward/record.url?scp=85041637201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041637201&partnerID=8YFLogxK

U2 - 10.1038/cmi.2016.60

DO - 10.1038/cmi.2016.60

M3 - Article

VL - 15

SP - 171

EP - 181

JO - Cellular and Molecular Immunology

JF - Cellular and Molecular Immunology

SN - 1672-7681

IS - 2

ER -